KRONOS BIO INC (KRON) 3.38 +0.03 (+0.9%)
3.38 +0.03 (+0.9%)
US50107A1043 - Common Stock - After market: 3.38 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 20.6. This target is 509.59% above the current price.
KRON was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about KRON.
In the previous month the buy percentage consensus was at a similar level.
KRON was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-09-14 | Berenberg | Initiate | Buy |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-05-23 | Piper Sandler | Maintains | Overweight |
| 2022-02-28 | Piper Sandler | Maintains | Overweight |
| 2021-11-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-24 | HC Wainwright & Co. | Initiate | Buy |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA